Cargando…
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
Kidney fibrosis is a common pathophysiological mechanism of chronic kidney disease (CKD) progression caused by several underlying kidney diseases. Among various contributors to kidney fibrosis, transforming growth factor-β1 (TGF-β1) is the major factor driving fibrosis. TGF-β1 exerts its profibrotic...
Autores principales: | Park, Cheol Ho, Yoo, Tae-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783223/ https://www.ncbi.nlm.nih.gov/pubmed/36558936 http://dx.doi.org/10.3390/ph15121485 |
Ejemplares similares
-
Targeting TGF-β Signaling in Kidney Fibrosis
por: Isaka, Yoshitaka
Publicado: (2018) -
Autophagy as a Therapeutic Target for Chronic Kidney Disease and the Roles of TGF-β1 in Autophagy and Kidney Fibrosis
por: Ruby, Miss, et al.
Publicado: (2023) -
TGF-β Pathway in Salivary Gland Fibrosis
por: Zhang, Xianglan, et al.
Publicado: (2020) -
Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
por: Lee, Chang-Min, et al.
Publicado: (2014) -
PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys
por: Kökény, Gábor, et al.
Publicado: (2021)